Insider Transactions in Q1 2025 at Molina Healthcare, Inc. (MOH)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
1,000
-5.44%
|
$301,000
$301.33 P/Share
|
|
Mar 01
2025
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+10.59%
|
$792,036
$294.62 P/Share
|
|
Mar 01
2025
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-4.34%
|
$288,659
$301.12 P/Share
|
|
Mar 01
2025
|
Debra Bacon EVP, Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
9,659
+26.63%
|
$2,839,746
$294.62 P/Share
|
|
Mar 01
2025
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
2,701
-11.03%
|
$813,001
$301.12 P/Share
|
|
Mar 01
2025
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,741
+7.94%
|
$3,745,854
$294.62 P/Share
|
|
Mar 01
2025
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,072
-4.18%
|
$1,827,672
$301.12 P/Share
|
|
Mar 01
2025
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
65,487
+7.68%
|
$19,253,178
$294.62 P/Share
|
|
Mar 01
2025
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,029
-3.76%
|
$8,737,729
$301.12 P/Share
|
|
Mar 01
2025
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,564
+10.87%
|
$4,575,816
$294.62 P/Share
|
|
Mar 01
2025
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,000
-4.04%
|
$1,505,000
$301.12 P/Share
|
|
Mar 01
2025
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,425
+14.14%
|
$5,710,950
$294.62 P/Share
|
|
Mar 01
2025
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,533
-6.66%
|
$2,267,433
$301.12 P/Share
|
|
Jan 01
2025
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
189
+1.02%
|
$54,999
$291.05 P/Share
|
|
Jan 01
2025
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+1.2%
|
$54,999
$291.05 P/Share
|
|
Jan 01
2025
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+6.34%
|
$54,999
$291.05 P/Share
|
|
Jan 01
2025
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
450
-6.9%
|
$130,950
$291.05 P/Share
|
|
Jan 01
2025
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+2.9%
|
$54,999
$291.05 P/Share
|
|
Jan 01
2025
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+4.28%
|
$54,999
$291.05 P/Share
|
|
Jan 01
2025
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
189
+1.58%
|
$54,999
$291.05 P/Share
|
|
Jan 01
2025
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
189
+2.63%
|
$54,999
$291.05 P/Share
|
|
Jan 01
2025
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
189
+1.07%
|
$54,999
$291.05 P/Share
|